PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 51 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | -100.0% | 106 | -99.2% | 0.00% | – |
Q1 2021 | $49,000 | +4.3% | 14,100 | 0.0% | 0.00% | – |
Q4 2020 | $47,000 | -4.1% | 14,100 | 0.0% | 0.00% | – |
Q3 2020 | $49,000 | -24.6% | 14,100 | 0.0% | 0.00% | – |
Q2 2020 | $65,000 | +38.3% | 14,100 | 0.0% | 0.00% | – |
Q1 2020 | $47,000 | -45.3% | 14,100 | 0.0% | 0.00% | – |
Q4 2019 | $86,000 | +45.8% | 14,100 | 0.0% | 0.00% | – |
Q3 2019 | $59,000 | -68.1% | 14,100 | 0.0% | 0.00% | – |
Q2 2019 | $185,000 | – | 14,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,319,000 | 2.90% |
NEA Management Company, LLC | 6,643,704 | $21,991,000 | 1.15% |
DAFNA Capital Management LLC | 320,542 | $1,061,000 | 0.44% |
Ghost Tree Capital, LLC | 497,074 | $1,645,000 | 0.44% |
Rock Springs Capital Management LP | 1,125,000 | $3,724,000 | 0.15% |
SABBY MANAGEMENT, LLC | 107,577 | $356,000 | 0.15% |
Platform Technology Partners | 34,750 | $115,000 | 0.10% |
Quantitative Systematic Strategies LLC | 10,938 | $36,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,500 | $607,000 | 0.01% |
Capital Advisory Group Advisory Services, LLC | 2,800 | $9,000 | 0.01% |